Catalysts About Meiji Holdings Meiji Holdings operates food and pharmaceutical businesses, with a focus on dairy, confectionery, nutrition products and prescription drugs including vaccines. What are the underlying business or industry changes driving this perspective?Read more
Meiji Holdings leans on selective price rises, factory upgrades, and faster overseas snack growth to protect profits as ingredient and shipping costs stay high. The key question is whether these moves can outweigh weaker spots like China operations and softer demand for its COVID vaccine.Read more
Meiji Holdings is trying to lift profits through factory changes and new health-focused businesses, but stubborn cost pressures and a tougher overseas backdrop could keep results from improving as much as many expect. The bigger question is whether shoppers keep accepting higher prices and whether its vaccine and new-drug bets deliver steady growth, or add more volatility.Read more
No trending discussion available.
Meiji Holdings Co., Ltd., together with its subsidiaries, manufactures and sells food products and pharmaceuticals in Japan, China, Asia, North America, Europe, and internationally. It operates in two segments, Food and Pharmaceuticals. The company offers milk, yogurt, cheese, ice cream, chocolate, gummy candy, protein, nutrition for infants and children, beauty supplements, and nutritional products. It also provides drugs for infectious diseases and central nervous system disorders, as well as vaccines, blood plasma products, generic drugs, and animal health products. The company was founded in 1916 and is headquartered in Chuo, Japan.
